Shuttle Pharmaceuticals Holdings Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Shuttle Pharmaceuticals Holdings Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Gaithersburg
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SHPH
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001757499
Board of directors
-
Adam Chambers V · DirectorSince 2025
-
Anatoly Dritschilo · Director · CEO and ChairmanSince 2023
-
Angel Liriano · DirectorSince 2025
-
Arachchige Sachin Eranga Pathigoda · DirectorSince 2025
-
Bette Jacobs · DirectorSince 2023
-
Chris Senanayake · DirectorSince 2024
-
George Scorsis · DirectorSince 2025
-
Joseph Tung · DirectorSince 2025
-
Joshua Schafer · DirectorSince 2025
-
Milton Brown · DirectorSince 2023
-
Oleh Nabyt · DirectorSince 2025
-
Steven M. Richards · DirectorSince 2023
Chief executives
Anatoly Dritschilo
· CEO and Chairman
Dates unknown
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.7%
-
95.4%
-
95.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $181,764
- 6 purchases by 1 insider
- Sold, last 12 months
- $504,832
- 5 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −82,116 | $4.48 | $367,880 |
| Jul 13, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −1,033 | $4.67 | $4,824 |
| Jul 10, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +731 | $3.11 | $2,273 |
| Jul 9, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +8,266 | $3.38 | $27,939 |
| Jul 8, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −18,531 | $3.52 | $65,229 |
| Jul 7, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −10,580 | $3.33 | $35,231 |
| Jul 6, 2026 | HRT FINANCIAL LP 10% owner | Open-market sale | −9,022 | $3.51 | $31,667 |
| Jul 2, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +7,851 | $3.54 | $27,793 |
| Jul 1, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +3,959 | $3.30 | $13,065 |
| Jun 30, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +6,755 | $3.23 | $21,819 |
| Jun 29, 2026 | HRT FINANCIAL LP 10% owner | Open-market purchase | +25,836 | $3.44 | $88,876 |
| Dec 31, 2024 | Joshua Schafer Director | Grant or award | +209,790 | — | — |
| Dec 31, 2024 | Steven M. Richards Director | Grant or award | +209,790 | — | — |
| Dec 23, 2024 | Milton Brown Director | Grant or award | +209,790 | — | — |
| May 1, 2024 | Jung Mira Officer (Chief Scientific Officer) | Grant or award | −598 | $11.28 | $6,745 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.